Embryo development and survival
- 专利权人:
- F. Neal Schrick
- 发明人:
- F. Neal Schrick
- 申请号：
- US12220978
- 公开号：
- US08715155B2
- 申请日:
- 2008.07.29
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- An embryo that is transferred into the uterus of a recipient female is protected from toxic effects of prostaglandin F2α by exposing the embryo, or an oocyte from which the embryo is produced, to a prostaglandin antagonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PAR-1 ANTAGONISTS FOR USE IN THE TREATMENT OR PREVENTION OF INFLUENZA VIRUS TYPE A INFECTIONS
- PAR-1 ANTAGONISTS FOR USE IN THE TREATMENT OR PREVENTION OF INFLUENZA VIRUS TYPE A INFECTIONS
- METHODS OF TREATING CANCER AND PREVENTING CANCER DRUG RESISTANCE
- USE OF CXCR2 ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY (CIPN)
- Use of CXCR2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
